angiotensin ii, sar(1)-me-tyr(4)- has been researched along with losartan in 8 studies
| Studies (angiotensin ii, sar(1)-me-tyr(4)-) | Trials (angiotensin ii, sar(1)-me-tyr(4)-) | Recent Studies (post-2010) (angiotensin ii, sar(1)-me-tyr(4)-) | Studies (losartan) | Trials (losartan) | Recent Studies (post-2010) (losartan) |
|---|---|---|---|---|---|
| 25 | 0 | 0 | 7,231 | 1,245 | 2,118 |
| Protein | Taxonomy | angiotensin ii, sar(1)-me-tyr(4)- (IC50) | losartan (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 9.01 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2.882 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.019 | |
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.0018 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.019 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0247 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0234 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.0032 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.047 | |
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | 0.025 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0118 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.019 | |
| Platelet glycoprotein VI | Homo sapiens (human) | 4 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.1481 | |
| Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.2884 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Entzeroth, M; Mauz, AB; Van Meel, JC; Wienen, W | 1 |
| Georgiev, V; Tchekalarova, J | 1 |
| Georgiev, V; Georgieva, D | 1 |
| Kolocouris, A; Matsoukas, J; Mavromoustakos, T; Roumelioti, P; Weisemann, R; Zervou, M | 1 |
| Alova, L; Georgiev, V; Stancheva, S | 1 |
| Georgiev, V; Kambourova, T; Matsoukas, J; Pechlivanova, D; Tchekalarova, J | 1 |
| Alova, L; Georgiev, V; Stancheva, S; Velkova, M | 1 |
| Benetis, NP; Giatas, N; Grdadolnik, SG; Kolocouris, A; Kyrikou, I; Matsoukas, J; Mavromoustakos, T; Minakakis, PM; Polevaya, L; Roumelioti, P; Vlahakos, D; Zervou, M; Zoga, A; Zoumpoulakis, P | 1 |
1 review(s) available for angiotensin ii, sar(1)-me-tyr(4)- and losartan
| Article | Year |
|---|---|
Conformation and bioactivity. Design and discovery of novel antihypertensive drugs.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Drug Design; Humans; Hypertension; Losartan; Magnetic Resonance Spectroscopy; Molecular Conformation; Molecular Mimicry; Peptides; Structure-Activity Relationship | 2004 |
7 other study(ies) available for angiotensin ii, sar(1)-me-tyr(4)- and losartan
| Article | Year |
|---|---|
Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Binding Sites; Biphenyl Compounds; Female; Imidazoles; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Losartan; Male; Muscle Contraction; Peptides; Rabbits; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Tetrazoles | 1992 |
Further evidence for interaction between angiotensin II and dopamine receptors (experiments on apomorphine stereotypy).
Topics: Angiotensin II; Animals; Apomorphine; Losartan; Male; Rats; Rats, Wistar; Receptors, Dopamine; Stereotyped Behavior | 1998 |
The role of angiotensin II and of its receptor subtypes in the acetic acid-induced abdominal constriction test.
Topics: Acetic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Colic; Imidazoles; Losartan; Male; Mice; Mice, Inbred ICR; Pain; Pain Measurement; Pyridines; Receptors, Angiotensin; Saralasin | 1999 |
An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Hypertension; Losartan; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Monte Carlo Method; Protein Conformation | 1999 |
The effects of peptide and nonpeptide angiotensin II-receptor ligands on the activity of brain monoamine oxidase in water-repleted rats.
Topics: Angiotensin II; Animals; Body Water; Brain; Drinking; Imidazoles; Isoenzymes; Ligands; Losartan; Male; Monoamine Oxidase; Peptides; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles | 2000 |
The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception.
Topics: Angiotensin II; Animals; Avoidance Learning; Disease Models, Animal; Drug Combinations; Imidazoles; Injections, Intraventricular; Kindling, Neurologic; Losartan; Male; Memory; Mice; Pain Measurement; Pentylenetetrazole; Pyridines; Seizures; Tail | 2003 |
The effects of peptide and nonpeptide antagonists of angiotensin II receptors on the noradrenaline uptake of different brain structures in rats with angiotensin II-induced increase of water intake.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Brain; Drinking Behavior; Imidazoles; Losartan; Male; Norepinephrine; Rats; Rats, Wistar; Saralasin; Tetrazoles | 2003 |